DEST.L
Price:
$3
Market Cap:
$2.87M
Destiny Pharma plc, a biotechnology company, focuses on the discovery, development, and commercialization of medicines for the treatment of infectious diseases in the United Kingdom. The company is involved in developing NTCD-M3 that is in Phase III clinical trial for the prevention of recurrent Clostridioides diffcile infections; XF-73 Nasal, which is in Phase II clinical trial for the prevention of post-surgical staphylococcal infection; and XF-73 Dermal that is in Phase I clinical trial for the treatment of skin infections of antibiotic resistant bacteria. It also develops SPOR-COV, biotherapeutic product, which is in preclinical stage for the prevention of COVID-19 and other viral respir...[Read more]
Industry
Biotechnology
IPO Date
2017-09-04
Stock Exchange
LSE
Ticker
DEST.L
According to Destiny Pharma plc’s latest financial reports and current stock price. The company's current PE Ratio is -0.50. This represents a change of -84.41% compared to the average of -3.21 of the last 4 quarters.
The mean historical PE Ratio of Destiny Pharma plc over the last ten years is -27.04. The current -0.50 PE Ratio has changed 84.93% with respect to the historical average. Over the past ten years (40 quarters), DEST.L's PE Ratio was at its highest in in the June 2020 quarter at -1.69. The PE Ratio was at its lowest in in the January 2015 quarter at -89.25.
Average
-27.04
Median
-11.50
Minimum
-86.89
Maximum
-4.00
Discovering the peaks and valleys of Destiny Pharma plc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 105.60%
Maximum Annual PE Ratio = -4.00
Minimum Annual Increase = -77.40%
Minimum Annual PE Ratio = -86.89
Year | PE Ratio | Change |
---|---|---|
2023 | -11.22 | 94.28% |
2022 | -5.77 | -50.95% |
2021 | -11.77 | 105.60% |
2020 | -5.73 | 43.10% |
2019 | -4.00 | -23.47% |
2018 | -5.23 | -67.89% |
2017 | -16.28 | -77.40% |
2016 | -72.04 | -17.08% |
2015 | -86.89 | 68.93% |
2014 | -51.43 | -47.63% |
The current PE Ratio of Destiny Pharma plc (DEST.L) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-9.59
5-year avg
-7.70
10-year avg
-27.04
Destiny Pharma plc’s PE Ratio is greater than ANGLE plc (-1.71), greater than Shield Therapeutics plc (-0.75), less than Polarean Imaging plc (-0.26), greater than Scancell Holdings plc (-12.66), greater than Faron Pharmaceuticals Oy (-10.69),
Company | PE Ratio | Market cap |
---|---|---|
-1.71 | $29.03M | |
-0.75 | $27.41M | |
-0.26 | $11.77M | |
-12.66 | $85.53M | |
-10.69 | $248.87M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Destiny Pharma plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Destiny Pharma plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Destiny Pharma plc's PE Ratio?
How is the PE Ratio calculated for Destiny Pharma plc (DEST.L)?
What is the highest PE Ratio for Destiny Pharma plc (DEST.L)?
What is the 3-year average PE Ratio for Destiny Pharma plc (DEST.L)?
What is the 5-year average PE Ratio for Destiny Pharma plc (DEST.L)?
How does the current PE Ratio for Destiny Pharma plc (DEST.L) compare to its historical average?